Article Text

Download PDFPDF

Oncologic Results and Surgical Morbidity of Laparoscopic Nerve-Sparing Radical Hysterectomy in the Treatment of FIGO Stage IB Cervical Cancer: Long-Term Follow-Up
  1. Nae Yoon Park, MD,
  2. Gun Oh Chong, MD,
  3. Dae Gy Hong, MD, PhD,
  4. Young Lae Cho, MD, PhD,
  5. Il Soo Park, MD, PhD and
  6. Yoon Soon Lee, MD, PhD
  1. Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University Hospital, Daegu, Korea.
  1. Address correspondence and reprint requests to Yoon Soon Lee, MD, Department of Obstetrics and Gynecology, Kyungpook National University Hospital, 50 Samdok-2Ga, Chung-Gu, Daegu 700-721, Korea. E-mail: yslee{at}knu.ac.kr.

Abstract

Objectives: The aim of this study was to evaluate a long-term follow-up data for oncologic results and surgical morbidity of a laparoscopic nerve-sparing radical hysterectomy (NSRH) in the treatment of FIGO stage IB cervical cancer.

Methods: This was a retrospective study that comprised consecutive 125 patients with cervical cancer stage IB1 (n = 105) and IB2 (n = 20) who underwent a laparoscopic NSRH (Piver type III) by a gynecologic oncologist without selecting patients from January 1999 to December 2007.

Results: In regression analysis, the operating time (R2 linear = 0.311, P < 0.001) and estimated blood loss (R2 linear = 0.261, P < 0.001) were decreased, whereas the number of harvested pelvic lymph nodes (R2 linear = 0.250, P < 0.001) was increased. Seventeen patients (13.6%, 17/125) were found to have pelvic node metastasis. Para-aortic node metastasis had occurred in 2 patients (5.1%, 2/39). There were high urological complications (13/125, 10.4%) related to radical surgery. Forty-one patients (33%) needed transfusions. Positive surgical margins did not exist. Patients were able to self-void at a mean of 10.3 days postoperatively. The return rates to normal voiding function at postoperative 14 and 21 days were 92.0% and 95.2%, respectively. Thirteen patients (IB1 n = 9, IB2 n = 4) experienced a recurrence postoperatively. Six patients (IB1 n = 3, IB2 n = 3) died of recurrent disease. Five-year disease-free survival rates of cervical cancer IB1 and IB2 were 92% and 78%, respectively (P = 0.1772). Five-year overall survival rates of cervical cancer IB1 and IB2 were 96% and 83%, respectively (P = 0.0437).

Conclusions: A laparoscopic NSRH for FIGO stage IB cervical cancer was comparable to open NSRH in terms of early recovery of bladder function. It did not compromise surgical radicality, but revealed high urological complications, long operating time, and much blood loss, compared with conventional radical hysterectomy. However, these surgical morbidities were corrected with increase in experiences.

  • Cervical cancer
  • Radical hysterectomy
  • Autonomic nerve-sparing
  • Laparoscopy
  • Stage IB

Statistics from Altmetric.com

Footnotes

  • The authors declare that there are no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.